Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 4/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA7 | P43166 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | TACR1 | P25103 | 2/20 | 0.36 |
| ▸ | MME | P08473 | 1/20 | 0.36 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.35 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23340707 | 0.90 | TSHR (0.40) | RCE1HTTCA1CA2CA7 | |
| SCHEMBL24052031 | 0.86 | RCE1 (0.40) | RCE1MAPTHTTCA1CA2 | |
| SCHEMBL20009805 | 0.83 | RCE1 (0.47) | RCE1MAPTHTTCA1CA2 | |
| SCHEMBL2554498 | 0.76 | TSHR (0.47) | HTTCA1CA2CA7CA9 | |
| SCHEMBL29913755 | 0.75 | RCE1 (0.51) | RCE1MAPTHTTTSHRKMT2A | |
| SCHEMBL18661849 | 0.75 | RCE1 (0.51) | RCE1MAPTHTTTSHRKMT2A | |
| SCHEMBL19356136 | 0.75 | KMT2A (0.49) | RCE1MAPTHTTCA1CA2 | |
| SCHEMBL19356374 | 0.75 | KMT2A (0.49) | RCE1MAPTHTTCA1CA2 | |
| SCHEMBL31074785 | 0.73 | TSHR (0.40) | MAPTHTTCA1CA2CA7 | |
| SCHEMBL15242244 | 0.73 | CA1 (0.51) | HTTCA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219990-A1 | METHOD FOR SYNTHESIZING C-NUCLEOSIDE COMPOUND | CHENGDU AUPONE PHARMACEUTICAL CO., LTD (CN) | 2023-07-13 | — | — | US | disclosed |
| EP-3573718-B1 | CYCLIC DINUCLEOTIDES AS STING AGONISTS | JANSSEN BIOTECH INC (US) | 2022-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219990-A1 | METHOD FOR SYNTHESIZING C-NUCLEOSIDE COMPOUND | RNGTT, NSUN2, PNP | RCE1 1512/4885MAPT 2942/4885HTT 4702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.